We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.15%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,185

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSC
1626
DELISTED
MTS Systems Corp
MTSC
$36K ﹤0.01%
525
-1,099
-68% -$77.6K
WOOF
1627
DELISTED
VCA Inc.
WOOF
$36K ﹤0.01%
658
-4,462
-87% -$236K
CAS
1628
DELISTED
A M Castle & Co
CAS
$36K ﹤0.01%
5,875
+5,448
+1,276% +$28K
CAG icon
1629
Conagra Brands
CAG
$7.18B
$35K ﹤0.01%
1,028
-1,448
-58% -$43.5K
CAPL icon
1630
CrossAmerica Partners
CAPL
$810M
$35K ﹤0.01%
1,239
+1,022
+471% +$32.6K
GLOB icon
1631
Globant
GLOB
$1.66B
$35K ﹤0.01%
1,147
-4,303
-79% -$109K
LUMN icon
1632
Lumen
LUMN
$6.26B
$35K ﹤0.01%
+1,200
New +$40.9K
NATH icon
1633
Nathan's Famous
NATH
$405M
$35K ﹤0.01%
+942
New +$40.5K
OC icon
1634
Owens Corning
OC
$12.3B
$35K ﹤0.01%
849
+277
+48% +$11.4K
OLED icon
1635
Universal Display
OLED
$3.95B
$35K ﹤0.01%
676
-2,315
-77% -$117K
TNK icon
1636
Teekay Tankers
TNK
$2.58B
$35K ﹤0.01%
670
+543
+428% +$29.2K
UVE icon
1637
Universal Insurance Holdings
UVE
$1.23B
$35K ﹤0.01%
1,464
+125
+9% +$3.19K
V icon
1638
Visa
V
$688B
$35K ﹤0.01%
522
-9,101
-95% -$617K
TEN
1639
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$35K ﹤0.01%
606
-1,309
-68% -$77.2K
MRLN
1640
DELISTED
Marlin Business Services Corp
MRLN
$35K ﹤0.01%
2,083
+1,635
+365% +$31K
BSTC
1641
DELISTED
BioSpecifics Technologies Corp.
BSTC
$35K ﹤0.01%
685
+131
+24% +$5.59K
I
1642
DELISTED
INTELSAT S. A.
I
$35K ﹤0.01%
3,516
-1,884
-35% -$21.2K
ECYT
1643
DELISTED
Endocyte, Inc. Common Stock
ECYT
$35K ﹤0.01%
+6,618
New +$39.7K
NWBO
1644
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$35K ﹤0.01%
3,498
-7,595
-68% -$66.5K
VXX
1645
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$35K ﹤0.01%
109
ANIK icon
1646
Anika Therapeutics
ANIK
$257M
$34K ﹤0.01%
1,026
+572
+126% +$20.4K
CACI icon
1647
CACI
CACI
$11.4B
$34K ﹤0.01%
418
-1,062
-72% -$92.3K
CASS icon
1648
Cass Information Systems
CASS
$731M
$34K ﹤0.01%
+800
New +$31.9K
EVC icon
1649
Entravision Communication
EVC
$1.07B
$34K ﹤0.01%
4,209
+612
+17% +$4.25K
GLRE icon
1650
Greenlight Captial
GLRE
$522M
$34K ﹤0.01%
1,156
-245
-17% -$7.48K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,185 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.